Repligen Valuation
| RGN Stock | EUR 141.40 1.55 1.11% |
At this time, the company appears to be fairly valued. Repligen holds a recent Real Value of €139.99 per share. The prevailing price of the company is €141.4. Our model determines the value of Repligen from analyzing the company fundamentals such as Shares Outstanding of 55.56 M, return on equity of 0.1, and Operating Margin of 0.25 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Repligen's price fluctuation is very steady at this time. Calculation of the real value of Repligen is based on 3 months time horizon. Increasing Repligen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Repligen stock is determined by what a typical buyer is willing to pay for full or partial control of Repligen. Since Repligen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Repligen Stock. However, Repligen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 141.4 | Real 139.99 | Hype 141.4 |
The real value of Repligen Stock, also known as its intrinsic value, is the underlying worth of Repligen Company, which is reflected in its stock price. It is based on Repligen's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Repligen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Repligen helps investors to forecast how Repligen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Repligen more accurately as focusing exclusively on Repligen's fundamentals will not take into account other important factors: Repligen Total Value Analysis
Repligen is at this time estimated to have takeover price of 8.44 B with market capitalization of 9.53 B, debt of 124.78 M, and cash on hands of 196.14 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Repligen fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.44 B | 9.53 B | 124.78 M | 196.14 M |
Repligen Investor Information
About 98.0% of the company shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 141.37. Repligen had not issued any dividends in recent years. Based on the analysis of Repligen's profitability, liquidity, and operating efficiency, Repligen is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Repligen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Repligen has an asset utilization ratio of 31.75 percent. This implies that the Company is making €0.32 for each dollar of assets. An increasing asset utilization means that Repligen is more efficient with each dollar of assets it utilizes for everyday operations.Repligen Ownership Allocation
Repligen owns a total of 55.56 Million outstanding shares. The majority of Repligen outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Repligen to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Repligen. Please pay attention to any change in the institutional holdings of Repligen as this could imply that something significant has changed or is about to change at the company. Also note that almost two million five hundred thirty-nine thousand two hundred eleven invesors are currently shorting Repligen expressing very little confidence in its future performance.Repligen Profitability Analysis
The company reported the revenue of 801.54 M. Net Income was 185.96 M with profit before overhead, payroll, taxes, and interest of 455.71 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Repligen's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Repligen and how it compares across the competition.
About Repligen Valuation
The stock valuation mechanism determines Repligen's current worth on a weekly basis. Our valuation model uses a comparative analysis of Repligen. We calculate exposure to Repligen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Repligen's related companies.Repligen Corporation develops, manufactures, and sells products used to enhance the interconnected phases of the biological drug manufacturing process in North America, Europe, APAC, and internationally. The company was founded in 1981 and is headquartered in Waltham, Massachusetts. REPLIGEN CORP operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 548 people.
8 Steps to conduct Repligen's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Repligen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Repligen's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Repligen's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Repligen's revenue streams: Identify Repligen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Repligen's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Repligen's growth potential: Evaluate Repligen's management, business model, and growth potential.
- Determine Repligen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Repligen's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Repligen Stock analysis
When running Repligen's price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |